Loading...
NPI 1467490433 · Lincoln, NE · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Urology Surgical Center LLC is a ambulatory surgical clinic/center provider located in Lincoln, Nebraska. This profile covers 20 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Urology Surgical Center LLC |
| Address | 5500 Pine Lake Rd |
| City | Lincoln |
| State | NE |
| ZIP | 68516 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | June 3, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.4M |
| Medicaid | $190.5K |
This entity is an ambulatory surgical clinic/center with a procedural mix heavily weighted toward diagnostic and therapeutic endoscopic urology and prostate procedures: high-volume cystourethroscopy (52000, 52310) appears throughout both payers, and the Medicare mix includes prostate-targeted interventions and implants (C9740, 55874, 55875) as well as sacral nerve electrode implantation (64561), consistent with an ASC focused on outpatient urologic interventions. The prominence of injection, implant, and brachytherapy source codes (e.g., C2642, J0585, 51715) further supports a specialized procedure suite rather than primary care or general surgery activity.
Medicare revenue is materially concentrated: the precomputed top 3 Medicare codes (52000, 55700, C9740) account for 46.3% of the provider's total Medicare revenue. Individually, 52000 contributes $265.3K (18.9% of Medicare revenue), 55700 contributes $197.8K (14.1%), and C9740 contributes $188.5K (13.4%), making these procedures central to the Medicare business profile.
Medicaid revenue is effectively mono-coded: the precomputed top 3 Medicaid codes account for 100.0% of Medicaid revenue and the portfolio is dominated by 52000, which generates $187.2K (98.5% of this provider's total Medicaid revenue). 52000 also ranks #1 of 4 providers in-state for that code, indicating this ASC is the leading Medicaid provider in Nebraska for basic cystourethroscopy volume.
The payer mix is Medicare-dominant on an absolute scale: total Medicare revenue is $1.4M versus total Medicaid revenue of $190.5K, so Medicare contributes the clear majority of billed dollars while Medicaid is a smaller, concentrated revenue stream for this entity. This asymmetry implies reimbursement and utilization changes in Medicare will have a larger financial impact than equivalent shifts in Medicaid volume.
National competitive standing shows extreme specialization on certain cystoscopy-related codes: 52000 ranks #11 of 8548 providers nationally and 52310 ranks #7 of 2547 providers (both described as 100th percentile; extreme outlier), and 55700 ranks #19 of 4425 providers (100th percentile; extreme outlier). By contrast, several higher-reimbursement or device-related codes (C9740, 64561) are in typical national percentile ranges (C9740 at the 68th percentile; 64561 at the 76th percentile), indicating the practice pairs very high-volume diagnostic/therapeutic cystoscopy with a more typical level of implant and specialty service activity.
At the state Medicaid level the provider is a leading source of cystourethroscopy services: 52000's rank of #1 of 4 in-state (100th percentile; typical, unremarkable volume in-state) shows the clinic captures a dominant share of Medicaid cystoscopy dollars locally despite the overall Medicaid revenue being modest. The concentrated Medicaid code mix (98.5% from 52000) suggests limited breadth of Medicaid-billed services relative to Medicare.
Operationally, the impending deletion of 55700 (code deleted December 31, 2025) is notable because that code currently represents $197.8K (14.1% of Medicare revenue) for this provider. Loss or replacement of 55700 will require billing adjustments or substitution to alternative codes for a meaningful portion of Medicare revenue unless case mix shifts away from services historically reported under that code.
The provider has an established presence with an NPI enumerated on 2006-06-03 (~20 years ago), indicating long tenure as an ASC. That longevity, coupled with persistent high-volume reporting on core cystoscopy codes (52000, 52310) across both payers, supports the characterization of a steady, procedure-centric outpatient urology center rather than a recently opened or generalist practice.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
20 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 1,290 | $210 | $265.3K |
| 55700 | Code deleted December 31, 2025. | 310 | $630 | $197.8K |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 30 | $5,550 | $188.5K |
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 40 | $3,840 | $168.9K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 210 | $640 | $131.8K |
| 55874 | Under imaging guidance, the provider inserts a needle through the perineum, the area between the anus and the scrotum, and injects one or more biodegradable materials, i.e., material that decomposes… | 30 | $2,740 | $87.6K |
| 52287 | The provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystoscope. He then inserts a needle and injects a neurolytic drug into the… | 90 | $650 | $55.6K |
| C2642 | Brachytherapy source, stranded, cesium-131, per source | 730 | $70 | $51.6K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 10,000 | $10 | $50K |
| 51715 | In this procedure, the provider injects a natural or synthetic material into the submucosal tissue of the urethra and or bladder neck using an endoscope, a stiff or flexible tubular instrument with a… | 30 | $1,570 | $40.7K |
Showing 1–10 of 20
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
20 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| C9740 | 2 | 10 | 30 | $5,440 | $157.7K |
| 64561 | 3 | 10 | 30 | $2,510 | $145.4K |
| J0585 | 13 | 30 | 8,400 | $1 | $69.1K |
| 55874 | 2 | 10 | 30 | $2,200 | $59.5K |
| C2642 | 1 | 10 | 730 | $70 | $51.7K |
| 52000 | 1 | 50 | 120 | $120 | $20.7K |
| 52287 | 4 | 20 | 30 | $340 | $20.2K |
| 52224 | 1 | 10 | 20 | $820 | $19.7K |
| 55875 | 1 | 10 | 10 | $1,740 | $19.2K |
| 51715 | 3 | 10 | 20 | $690 | $17.3K |
Showing 1–10 of 20
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 810 | $230 | $187.2K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 10 | $240 | $2.9K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 10 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 10 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Nebraska providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Nebraska median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 1 | 10 | 20 | $240 | $50.6K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 1 | 10 | 10 | $240 | $2.9K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 15 | 20 | 40 | $1 | $10 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 6 | 10 | 20 | $0 | $0 |
Other providers in the same ZIP code as Urology Surgical Center LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Melvin Churchill | NE | Rheumatology Physician | $4.8M | $0 |
| Lincoln Radiology Group PC | NE | Diagnostic Radiology Physician | $0 | $4.5M |
| Elite Professionals Home Care LLC | NE | Home Health Agency | $0 | $4.2M |
| Rick Chatwell | NE | Rheumatology Physician | $3.5M | $0 |
| Lincoln Pediatric Group LLC | NE | Pediatrics Physician | $0 | $2.3M |
| Scott Mcham | NE | Hematology & Oncology Physician | $1.9M | $0 |
| Nebraska House Call Physicians, P.C. | NE | Internal Medicine Physician | $0 | $1.7M |
| Steven Dunder | NE | Hematology & Oncology Physician | $1.7M | $0 |
| Wallace Peterson | NE | Hematology & Oncology Physician | $1.5M | $0 |
| Irfan Vaziri | NE | Medical Oncology Physician | $1.4M | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.